Back

One-year right heart failure outcomes in patients with severe tricuspid regurgitation in the TRISCEND II trial

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Interventional cardiology Tricuspid Valve Intervention HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Michaela Hell

University Medical Centre of the Johannes Gutenberg University, Mainz (Germany)

6 More presentations in this session

Presentation thumbnail
Improvement of mitral regurgitation following transcatheter aortic valve implantation: outcomes and predictors in a retrospective cohort study
Doctor M. Paralta De Figueiredo (Evora, PT)
Abstract Slides Video
Presentation thumbnail
Preservation dilemma: prognosis across the preserved spectrum of transcatheter aortic valve replacement patients for severe aortic stenosis
Doctor T. Pereira dos Santos (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Antithrombotic therapy after valve-in-valve, valve-in-ring and valve-in-MAC: review and metaanalysis
Doctor G. Terleira Batista (Coimbra, PT) Doctor M. Rodrigues Simoes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
A single-centre perspective on survival and complications after transcatheter aortic valve replacement in chronic kidney disease and end-stage renal disease patients
Doctor T. Pereira dos Santos (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Unlocking recovery: predictors and outcomes of left ventricular dysfunction after TAVI
Doctor S. Esteves (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional cardiology

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
A randomised trial of transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation: TRISCEND II trial
thumbnail
Congress Presentation
Serial cardiac remodeling and organ function changes after transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation: Importance of multimodal assessment post-TTVR
thumbnail
Congress Presentation
Edge-to-edge repair for tricuspid valve regurgitation: 1-year follow up and clinical implications from the TR- Interventional Study (TRIS)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources